U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula CHCl3
Molecular Weight 119.3775
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of CHLOROFORM

SMILES

C(Cl)(Cl)Cl

InChI

InChIKey=HEDRZPFGACZZDS-UHFFFAOYSA-N
InChI=1S/CHCl3/c2-1(3)4/h1H

HIDE SMILES / InChI

Molecular Formula CHCl3
Molecular Weight 119.3775
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Chloroform is a colorless, sweet-smelling, dense liquid and widely used industrial and laboratory solvent. The total global flux of chloroform through the environment is approximately 660 000 tonnes per year, and about 90% of emissions are natural in origin. Many kinds of seaweed produce chloroform, and fungi are believed to produce chloroform in soil. Chloroform is used as an industrial solvent and as an intermediate in the manufacture of polymeric materials. The major use of chloroformtoday is in the production of the refrigerant R-22, commonly used in the air conditioning business. Inhaled chloroform anesthesia was introduced in 1847 and Chloroform subsequently became the most widely used volatile anaesthetic, and was used in horses before the end of the 19th century. Pure chloroform is known to be decomposed by the air with the formation of hydrochloric acid, phosgene and carbon dioxide. Phosgene is also generated metabolically from chloroform, and liver and kidney damage can ensue from its production.

Approval Year

AUC

AUC

ValueDoseCo-administeredAnalytePopulation
176 μg × min/mL
500 mg single, oral
dose: 500 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
CHLOROFORM blood
Homo sapiens
population: UNKNOWN
age: UNKNOWN
sex: FEMALE
food status: UNKNOWN
293 μg × min/mL
500 mg single, oral
dose: 500 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
CHLOROFORM blood
Homo sapiens
population: UNKNOWN
age: UNKNOWN
sex: MALE
food status: UNKNOWN
T1/2

T1/2

ValueDoseCo-administeredAnalytePopulation
86 min
500 mg single, oral
dose: 500 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
CHLOROFORM blood
Homo sapiens
population: UNKNOWN
age: UNKNOWN
sex: FEMALE
food status: UNKNOWN
96 min
500 mg single, oral
dose: 500 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
CHLOROFORM blood
Homo sapiens
population: UNKNOWN
age: UNKNOWN
sex: MALE
food status: UNKNOWN
Doses

Doses

DosePopulationAdverse events​
30 mL single, oral (max)
Overdose
Dose: 30 mL
Route: oral
Route: single
Dose: 30 mL
Sources: Page: p.1,2
healthy, 30
n = 1
Health Status: healthy
Age Group: 30
Sex: F
Population Size: 1
Sources: Page: p.1,2
Disc. AE: Loss of consciousness, Hypotension...
AEs leading to
discontinuation/dose reduction:
Loss of consciousness
Hypotension
Respiratory depression (severe)
Abdominal pain (severe)
Vomiting
Diarrhea
Enterocolitis (severe)
Erosive oesophagitis (severe)
Gastritis erosive (severe)
Ulceration (severe)
Contact dermatitis
ALT increased
AST increased
Sources: Page: p.1,2
73 g/m3 single, respiratory
Recommended
Dose: 73 g/m3
Route: respiratory
Route: single
Dose: 73 g/m3
Sources: Page: p.26
unknown
Health Status: unknown
Condition: anaesthesia
Sources: Page: p.26
Disc. AE: Respiratory failure, Cardiac arrhythmias...
AEs leading to
discontinuation/dose reduction:
Respiratory failure (grade 5)
Cardiac arrhythmias (grade 5)
Cardiac failure (grade 5)
Sources: Page: p.26
1030 ppm single, respiratory
Studied dose
Dose: 1030 ppm
Route: respiratory
Route: single
Dose: 1030 ppm
Sources:
healthy
Health Status: healthy
Sources:
Disc. AE: Dizziness, Intracranial pressure increase...
AEs leading to
discontinuation/dose reduction:
Dizziness
Intracranial pressure increase
Nausea
Headache
Sources:
AEs

AEs

AESignificanceDosePopulation
ALT increased Disc. AE
30 mL single, oral (max)
Overdose
Dose: 30 mL
Route: oral
Route: single
Dose: 30 mL
Sources: Page: p.1,2
healthy, 30
n = 1
Health Status: healthy
Age Group: 30
Sex: F
Population Size: 1
Sources: Page: p.1,2
AST increased Disc. AE
30 mL single, oral (max)
Overdose
Dose: 30 mL
Route: oral
Route: single
Dose: 30 mL
Sources: Page: p.1,2
healthy, 30
n = 1
Health Status: healthy
Age Group: 30
Sex: F
Population Size: 1
Sources: Page: p.1,2
Contact dermatitis Disc. AE
30 mL single, oral (max)
Overdose
Dose: 30 mL
Route: oral
Route: single
Dose: 30 mL
Sources: Page: p.1,2
healthy, 30
n = 1
Health Status: healthy
Age Group: 30
Sex: F
Population Size: 1
Sources: Page: p.1,2
Diarrhea Disc. AE
30 mL single, oral (max)
Overdose
Dose: 30 mL
Route: oral
Route: single
Dose: 30 mL
Sources: Page: p.1,2
healthy, 30
n = 1
Health Status: healthy
Age Group: 30
Sex: F
Population Size: 1
Sources: Page: p.1,2
Hypotension Disc. AE
30 mL single, oral (max)
Overdose
Dose: 30 mL
Route: oral
Route: single
Dose: 30 mL
Sources: Page: p.1,2
healthy, 30
n = 1
Health Status: healthy
Age Group: 30
Sex: F
Population Size: 1
Sources: Page: p.1,2
Loss of consciousness Disc. AE
30 mL single, oral (max)
Overdose
Dose: 30 mL
Route: oral
Route: single
Dose: 30 mL
Sources: Page: p.1,2
healthy, 30
n = 1
Health Status: healthy
Age Group: 30
Sex: F
Population Size: 1
Sources: Page: p.1,2
Vomiting Disc. AE
30 mL single, oral (max)
Overdose
Dose: 30 mL
Route: oral
Route: single
Dose: 30 mL
Sources: Page: p.1,2
healthy, 30
n = 1
Health Status: healthy
Age Group: 30
Sex: F
Population Size: 1
Sources: Page: p.1,2
Abdominal pain severe
Disc. AE
30 mL single, oral (max)
Overdose
Dose: 30 mL
Route: oral
Route: single
Dose: 30 mL
Sources: Page: p.1,2
healthy, 30
n = 1
Health Status: healthy
Age Group: 30
Sex: F
Population Size: 1
Sources: Page: p.1,2
Enterocolitis severe
Disc. AE
30 mL single, oral (max)
Overdose
Dose: 30 mL
Route: oral
Route: single
Dose: 30 mL
Sources: Page: p.1,2
healthy, 30
n = 1
Health Status: healthy
Age Group: 30
Sex: F
Population Size: 1
Sources: Page: p.1,2
Erosive oesophagitis severe
Disc. AE
30 mL single, oral (max)
Overdose
Dose: 30 mL
Route: oral
Route: single
Dose: 30 mL
Sources: Page: p.1,2
healthy, 30
n = 1
Health Status: healthy
Age Group: 30
Sex: F
Population Size: 1
Sources: Page: p.1,2
Gastritis erosive severe
Disc. AE
30 mL single, oral (max)
Overdose
Dose: 30 mL
Route: oral
Route: single
Dose: 30 mL
Sources: Page: p.1,2
healthy, 30
n = 1
Health Status: healthy
Age Group: 30
Sex: F
Population Size: 1
Sources: Page: p.1,2
Respiratory depression severe
Disc. AE
30 mL single, oral (max)
Overdose
Dose: 30 mL
Route: oral
Route: single
Dose: 30 mL
Sources: Page: p.1,2
healthy, 30
n = 1
Health Status: healthy
Age Group: 30
Sex: F
Population Size: 1
Sources: Page: p.1,2
Ulceration severe
Disc. AE
30 mL single, oral (max)
Overdose
Dose: 30 mL
Route: oral
Route: single
Dose: 30 mL
Sources: Page: p.1,2
healthy, 30
n = 1
Health Status: healthy
Age Group: 30
Sex: F
Population Size: 1
Sources: Page: p.1,2
Cardiac arrhythmias grade 5
Disc. AE
73 g/m3 single, respiratory
Recommended
Dose: 73 g/m3
Route: respiratory
Route: single
Dose: 73 g/m3
Sources: Page: p.26
unknown
Health Status: unknown
Condition: anaesthesia
Sources: Page: p.26
Cardiac failure grade 5
Disc. AE
73 g/m3 single, respiratory
Recommended
Dose: 73 g/m3
Route: respiratory
Route: single
Dose: 73 g/m3
Sources: Page: p.26
unknown
Health Status: unknown
Condition: anaesthesia
Sources: Page: p.26
Respiratory failure grade 5
Disc. AE
73 g/m3 single, respiratory
Recommended
Dose: 73 g/m3
Route: respiratory
Route: single
Dose: 73 g/m3
Sources: Page: p.26
unknown
Health Status: unknown
Condition: anaesthesia
Sources: Page: p.26
Dizziness Disc. AE
1030 ppm single, respiratory
Studied dose
Dose: 1030 ppm
Route: respiratory
Route: single
Dose: 1030 ppm
Sources:
healthy
Health Status: healthy
Sources:
Headache Disc. AE
1030 ppm single, respiratory
Studied dose
Dose: 1030 ppm
Route: respiratory
Route: single
Dose: 1030 ppm
Sources:
healthy
Health Status: healthy
Sources:
Intracranial pressure increase Disc. AE
1030 ppm single, respiratory
Studied dose
Dose: 1030 ppm
Route: respiratory
Route: single
Dose: 1030 ppm
Sources:
healthy
Health Status: healthy
Sources:
Nausea Disc. AE
1030 ppm single, respiratory
Studied dose
Dose: 1030 ppm
Route: respiratory
Route: single
Dose: 1030 ppm
Sources:
healthy
Health Status: healthy
Sources:
Overview

Overview

CYP3A4CYP2C9CYP2D6hERG

OverviewOther

Other InhibitorOther SubstrateOther Inducer




Drug as victimTox targets

Tox targets

TargetModalityActivityMetaboliteClinical evidence
PubMed

PubMed

TitleDatePubMed
Herpes zoster and post-herpetic neuralgia--a clinical trial of aspirin in chloroform for anodyne.
1998 Apr
Inhibition of spontaneous induction of lambdoid prophages in Escherichia coli cultures: simple procedures with possible biotechnological applications.
2001
Polymorphisms in the Mn-SOD and EC-SOD genes and their relationship to diabetic neuropathy in type 1 diabetes mellitus.
2001
Catalytic effect of soil colloids on the reaction between CrVI and p-methoxyphenol.
2001
Analysis of triacylglycerols with non-aqueous reversed-phase liquid chromatography and positive ion electrospray tandem mass spectrometry.
2001
[New studies on the history of anesthesiology--(7). What anesthetics were given to soldiers of the fifth regiment rescued from death march on Mount Hakkoda?].
2001 Apr
Labdane and pimarane diterpenes from Croton joufra.
2001 Apr
Two stereoisomeric pentacyclic oxindole alkaloids from Uncaria tomentosa: uncarine C and uncarine E.
2001 Apr
Inhibiting effects of chloroform on anaerobic microbial consortia as monitored by the Rantox biosensor.
2001 Apr
First isolation and characterization of eight regioisomers for [60]fullerene-benzene bisadducts.
2001 Apr 19
Oxidative degradation study of nitrendipine using stability indicating, HPLC, HPTLC and spectrophotometric method.
2001 Feb
A liquid chromatographic method for the simultaneous determination of promethazine and three of its metabolites in plasma using electrochemical and UV detectors.
2001 Feb
DNA isolation from chloroform/methanol-treated mycobacterial cells without lysozyme and proteinase K.
2001 Feb
Enhanced biodegradation of cyclotetramethylenetetranitramine (HMX) under mixed electron-acceptor condition.
2001 Feb
Carbon tetrachloride dechlorination by the bacterial transition metal chelator pyridine-2,6-bis(thiocarboxylic acid).
2001 Feb 1
Reductive dechlorination of cis-1,2-dichloroethene and vinyl chloride by "Dehalococcoides ethenogenes".
2001 Feb 1
Fluorometric method for the simultaneous quantitation of differently-sized nanoparticles in rodent tissue.
2001 Feb 19
Correlation of a specific mitochondrial phospholipid-phosgene adduct with chloroform acute toxicity.
2001 Feb 21
The (1)H NMR chemical shift for the hydroxy proton of 4-(dimethylamino)-2'-hydroxychalcone in chloroform: a theoretical approach to its inverse dependence on the temperature.
2001 Feb 22
Mitochondrial medicine--molecular pathology of defective oxidative phosphorylation.
2001 Jan
Direct measurements of hemoglobin interactions with liposomes using EPR spectroscopy.
2001 Jan
Trianthenol: an antifungal tetraterpenoid from Trianthema portulacastrum (Aizoaceae).
2001 Jan
Methylation of neutral pseudotetrahedral zinc thiolate complexes: model reactions for alkyl group transfer to sulfur by zinc-containing enzymes.
2001 Jan
A 1:1:1 chloroform/tetrahydrofuran solvate of p-tert-butyltetrahomodioxacalix[4]arene.
2001 Jan
Chronic toxicity of chloroform to Japanese medaka fish.
2001 Jan
Augmented expression of peroxiredoxin VI in rat lung and kidney after birth implies an antioxidative role.
2001 Jan
Preparations, characterizations, and structures of (biimidazole)dihalobis(triphenylphosphine)rhenium(III) salts: strong ion-pairing and acid-base properties.
2001 Jan 1
Platinum(II) and palladium(II) complexes with dithiocarbamates and amines: synthesis, characterization and cell assay.
2001 Jan 1
Phenylisoserine: a versatile amino acid for the construction of novel beta-peptide structures.
2001 Jan 10
Occupational exposure to trihalomethanes in indoor swimming pools.
2001 Jan 17
Degradation behaviors of biodegradable macroporous scaffolds prepared by gas foaming of effervescent salts.
2001 Jun 5
Extraction of iridium (IV) from hydrochloric acid media with crown ether in chloroform, and its determination by ICP-AES.
2001 Mar
A new spectrophotometric method for the determination of total and ferric iron in rain water at the ppb level.
2001 Mar
The role of nitric oxide on cigarette smoke-induced programmed cell death in the gastric mucosa.
2001 Mar
Biosynthesis of PHB tercopolymer by Bacillus cereus UW85.
2001 Mar
Molecular mechanisms of anesthesia.
2001 Mar
Transient absorption from the 1Bu+ state of all-trans-beta-carotene newly identified in the near-infrared region.
2001 Mar
Anion recognition by thiostrepton.
2001 Mar 12
Photochemistry of the pi-extended 9,10-bis(1,3-dithiol-2-ylidene)-9,10-dihydroanthracene system: generation and characterisation of the radical cation, dication, and derived products.
2001 Mar 2
Genomic and functional characteristics of novel human pancreatic 2P domain K(+) channels.
2001 Mar 23
Chloroform-soluble schiff-base Zn(II) or Cd(II) complexes from a dynamic combinatorial library.
2001 Mar 26
Synthesis, aggregation, and binding behavior of synthetic amphiphilic receptors.
2001 Mar 9
Fabrication of poly(phosphoester) nerve guides by immersion precipitation and the control of porosity.
2001 May
A controlled field experiment on groundwater contamination by a multicomponent DNAPL: creation of the emplaced-source and overview of dissolved plume development.
2001 May
Cytotoxic activity of Typhonium flagelliforme (Araceae).
2001 May
Evaluation of extraction methods from paraffin wax embedded tissues for PCR amplification of human and viral DNA.
2001 May
Screening of various Swertia species extracts in primary monolayer cultures of rat hepatocytes against carbon tetrachloride- and paracetamol-induced toxicity.
2001 May
Bactericidal properties of the chloroform fraction from rhizomes of Aristolochia paucinervis Pomel.
2001 May
Topical anti-inflammatory activity of Salvia officinalis L. leaves: the relevance of ursolic acid.
2001 May
Evaluation of diimine ligand exchange on Cu(I).
2001 May 21
Substance Class Chemical
Created
by admin
on Sat Jun 26 12:06:08 UTC 2021
Edited
by admin
on Sat Jun 26 12:06:08 UTC 2021
Record UNII
7V31YC746X
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
CHLOROFORM
GREEN BOOK   HSDB   II   INCI   MART.   MI   VANDF   WHO-DD  
INCI  
Official Name English
CHLOROFORM [GREEN BOOK]
Common Name English
CHLOROFORM [USP-RS]
Common Name English
CHLOROFORM [MART.]
Common Name English
CHLOROFORM [II]
Common Name English
CHLOROFORM [MI]
Common Name English
NSC-77361
Code English
CHLOROFORM [VANDF]
Common Name English
HCC 20
Common Name English
CHLOROBUTANOL IMPURITY A [EP]
Common Name English
CHLOROFORM [HSDB]
Common Name English
CHLOROFORM BP
Common Name English
CHLOROFORM [WHO-DD]
Common Name English
CHLOROFORM [INCI]
Common Name English
R 20 (REFRIGERANT)
Common Name English
METHANE, TRICHLORO-
Systematic Name English
TRICHLOROMETHANE
Systematic Name English
CHLOROFORMUM [HPUS]
Common Name English
CHLOROFORM [IARC]
Common Name English
CHLOROFORMUM
HPUS  
Common Name English
Classification Tree Code System Code
EPA PESTICIDE CODE 20701
Created by admin on Sat Jun 26 12:06:09 UTC 2021 , Edited by admin on Sat Jun 26 12:06:09 UTC 2021
WHO-VATC QN01AB02
Created by admin on Sat Jun 26 12:06:09 UTC 2021 , Edited by admin on Sat Jun 26 12:06:09 UTC 2021
NCI_THESAURUS C45386
Created by admin on Sat Jun 26 12:06:09 UTC 2021 , Edited by admin on Sat Jun 26 12:06:09 UTC 2021
IARC Chloroform
WHO-ATC N01AB02
Created by admin on Sat Jun 26 12:06:09 UTC 2021 , Edited by admin on Sat Jun 26 12:06:09 UTC 2021
CFR 21 CFR 310.502
Created by admin on Sat Jun 26 12:06:09 UTC 2021 , Edited by admin on Sat Jun 26 12:06:09 UTC 2021
CFR 21 CFR 700.18
Created by admin on Sat Jun 26 12:06:09 UTC 2021 , Edited by admin on Sat Jun 26 12:06:09 UTC 2021
Code System Code Type Description
CAS
67-66-3
Created by admin on Sat Jun 26 12:06:09 UTC 2021 , Edited by admin on Sat Jun 26 12:06:09 UTC 2021
PRIMARY
ECHA (EC/EINECS)
200-663-8
Created by admin on Sat Jun 26 12:06:09 UTC 2021 , Edited by admin on Sat Jun 26 12:06:09 UTC 2021
PRIMARY
DRUG CENTRAL
4363
Created by admin on Sat Jun 26 12:06:09 UTC 2021 , Edited by admin on Sat Jun 26 12:06:09 UTC 2021
PRIMARY
HSDB
56
Created by admin on Sat Jun 26 12:06:09 UTC 2021 , Edited by admin on Sat Jun 26 12:06:09 UTC 2021
PRIMARY
NCI_THESAURUS
C45678
Created by admin on Sat Jun 26 12:06:09 UTC 2021 , Edited by admin on Sat Jun 26 12:06:09 UTC 2021
CONCEPT Industrial Aid
MERCK INDEX
M3412
Created by admin on Sat Jun 26 12:06:09 UTC 2021 , Edited by admin on Sat Jun 26 12:06:09 UTC 2021
PRIMARY Merck Index
ChEMBL
CHEMBL44618
Created by admin on Sat Jun 26 12:06:09 UTC 2021 , Edited by admin on Sat Jun 26 12:06:09 UTC 2021
PRIMARY
EPA CompTox
67-66-3
Created by admin on Sat Jun 26 12:06:09 UTC 2021 , Edited by admin on Sat Jun 26 12:06:09 UTC 2021
PRIMARY
EVMPD
SUB13331MIG
Created by admin on Sat Jun 26 12:06:09 UTC 2021 , Edited by admin on Sat Jun 26 12:06:09 UTC 2021
PRIMARY
EVMPD
SUB13333MIG
Created by admin on Sat Jun 26 12:06:09 UTC 2021 , Edited by admin on Sat Jun 26 12:06:09 UTC 2021
ALTERNATIVE
NCI_THESAURUS
C29815
Created by admin on Sat Jun 26 12:06:09 UTC 2021 , Edited by admin on Sat Jun 26 12:06:09 UTC 2021
PRIMARY
MESH
D002725
Created by admin on Sat Jun 26 12:06:09 UTC 2021 , Edited by admin on Sat Jun 26 12:06:09 UTC 2021
PRIMARY
USP_CATALOG
1601383
Created by admin on Sat Jun 26 12:06:09 UTC 2021 , Edited by admin on Sat Jun 26 12:06:09 UTC 2021
PRIMARY USP-RS
RXCUI
1362698
Created by admin on Sat Jun 26 12:06:09 UTC 2021 , Edited by admin on Sat Jun 26 12:06:09 UTC 2021
PRIMARY RxNorm
PUBCHEM
6212
Created by admin on Sat Jun 26 12:06:09 UTC 2021 , Edited by admin on Sat Jun 26 12:06:09 UTC 2021
PRIMARY
FDA UNII
7V31YC746X
Created by admin on Sat Jun 26 12:06:09 UTC 2021 , Edited by admin on Sat Jun 26 12:06:09 UTC 2021
PRIMARY
WIKIPEDIA
CHLOROFORM
Created by admin on Sat Jun 26 12:06:09 UTC 2021 , Edited by admin on Sat Jun 26 12:06:09 UTC 2021
PRIMARY
DRUG BANK
DB11387
Created by admin on Sat Jun 26 12:06:09 UTC 2021 , Edited by admin on Sat Jun 26 12:06:09 UTC 2021
PRIMARY
EVMPD
SUB29129
Created by admin on Sat Jun 26 12:06:09 UTC 2021 , Edited by admin on Sat Jun 26 12:06:09 UTC 2021
PRIMARY
Related Record Type Details
METABOLIC ENZYME -> SUBSTRATE
METABOLIC ENZYME -> SUBSTRATE
Related Record Type Details
METABOLITE TOXIC -> PARENT
Renal tubular and hepatic necrosis in man.
Related Record Type Details
PARENT -> IMPURITY
PARENT -> IMPURITY
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
Related Record Type Details
ACTIVE MOIETY